Philips provides update on Respironics recall

Together with five independent, certified testing laboratories, Philips Respironics conducted extensive testing. Based on the results to date, Philips Respironics concluded that use of its sleep therapy devices are not expected to result in appreciable harm to health in patients.

Following ongoing communications with the FDA, Philips Respironics has agreed with the FDA’s recommendations to implement additional testing on certain sleep and respiratory care devices to supplement current test data.

The FDA stated that the testing is extensive and conducted with independent parties and expressed no concerns with the validity or objectivity of the testing. Philips Respironics is still in discussions with the FDA on the details of further testing.

Philips is committed to securing patient safety and quality in everything we do.